![Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup | Science Translational Medicine Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abc4834/asset/82ba13bb-f878-434d-aca2-43513f5d7abf/assets/graphic/abc4834-f2.jpeg)
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup | Science Translational Medicine
![Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup | Science Translational Medicine Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abc4834/asset/6d3abaca-6144-4fd1-a78b-6f5ec8269a12/assets/graphic/abc4834-f4.jpeg)
Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup | Science Translational Medicine
![Antibiotics | Free Full-Text | Development of an NGS-Based Workflow for Improved Monitoring of Circulating Plasmids in Support of Risk Assessment of Antimicrobial Resistance Gene Dissemination Antibiotics | Free Full-Text | Development of an NGS-Based Workflow for Improved Monitoring of Circulating Plasmids in Support of Risk Assessment of Antimicrobial Resistance Gene Dissemination](https://www.mdpi.com/antibiotics/antibiotics-09-00503/article_deploy/html/images/antibiotics-09-00503-g001.png)
Antibiotics | Free Full-Text | Development of an NGS-Based Workflow for Improved Monitoring of Circulating Plasmids in Support of Risk Assessment of Antimicrobial Resistance Gene Dissemination
![Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup | Science Translational Medicine Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abc4834/asset/900746d5-be2e-4e03-9f8b-c906be1228c2/assets/graphic/abc4834-f1.jpeg)